MPM BioVentures 2014, L.P.

13F Holdings History for Werewolf Therapeutics, Inc. - Common Stock (HOWL)

Symbol: HOWL on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 5.48M shares
Security Ownership: 11.3%

ANSBERT GADICKE ownership in Werewolf Therapeutics, Inc. Common Stock (HOWL)

2025-11-17 - ANSBERT GADICKE has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.48M shares of Werewolf Therapeutics, Inc. Common Stock (HOWL). This represents 11.3% percent ownership of the company. In their previous filing dated 2025-11-04, MPM BioVentures 2014, L.P. had reported owning 6.15M shares, indicating a decrease of -10.8% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
ANSBERT GADICKE	11.3%	-16.2%	$7.67M	5.48M	-666,071	-10.8%	$1.40	13D/A	11/13/2025	17 Nov 2025 20:00:40
ANSBERT GADICKE	13.4%		$12.1M	6.15M			$1.97	13D/A	10/31/2025	4 Nov 2025 18:33:09